NCT00507091 Phase I Irinotecan, 5-Fluorouracil and Leucovorin Combination Status COMPLETED Phase PHASE1
NCT00499603 Paclitaxel Followed by FEC Versus Paclitaxel and RAD001 Followed by FEC In Women With Breast Cancer Status UNKNOWN Phase PHASE2
NCT00469443 Randomized Phase III Study of Folfiri+Avastin Versus Xeliri+Avastin as 1st Line Treatment of CRC Status COMPLETED Phase PHASE3
NCT00418938 SPIRITT - Second-Line Panitumumab Irinotecan Treatment Trial Status COMPLETED Phase PHASE2
NCT00417209 Larotaxel Compared To Continuous Administration of 5-FU in Advanced Pancreatic Cancer Patients Previously Treated With A Gemcitabine-Containing Regimen Status COMPLETED Phase PHASE3
NCT00402545 C-TPF in Patients With Newly Diagnosed Locally Advanced Squamous Cell Carcinoma of the Head and Neck Status COMPLETED Phase PHASE1
NCT00400205 Study of Induction Docetaxel, Cisplatin and 5-Fluorouracil Status TERMINATED Phase PHASE2
NCT00386516 Study to Test the Benefit and Safety of GM-CT-01 in Combination With 5-FU to Treat Bile Duct and Gall Bladder Cancer Status WITHDRAWN Phase PHASE2
NCT00378716 Combination Chemotherapy in Treating Patients With Resected Colon Cancer Status COMPLETED Phase PHASE3
NCT00354978 Study of FOLFIRI Plus Bevacizumab in Colorectal Cancer Patients Status COMPLETED Phase PHASE2
NCT00346489 Outcomes of Intraoperative 5-Fluorouracil Versus Mitomycin C Status COMPLETED Phase PHASE4
NCT00336791 Randomized Clinical Trial to Evaluate the Predictive Accuracy of a Gene Expression for Stage I-II Breast Cancer Status COMPLETED Phase PHASE3
NCT00331097 ELDA: Elderly Breast Cancer - Docetaxel in Adjuvant Treatment Status COMPLETED Phase PHASE3
NCT00323583 Weekly Dosing of an Integrative Chemotherapy Combination to Treat Advanced Pancreatic Cancer Status UNKNOWN Phase PHASE2
NCT00308516 5-Fluorouracil, Bevacizumab, and Radiation Followed by Modified FOLFOX6 and Bevacizumab in Stage II/III Rectal Cancer Status COMPLETED Phase PHASE2
NCT00307736 Bevacizumab, Erlotinib and 5-Fluorouracil With External Beam Radiation Therapy in Locally Advanced Rectal Cancer Status COMPLETED Phase PHASE1/PHASE2
NCT00307723 Study of Bevacizumab in Combination With 5-FU, Oxaliplatin and External Beam Radiation Followed by Gemcitabine and Bevacizumab for Locally Advanced Pancreatic Cancer Status TERMINATED Phase PHASE1/PHASE2
NCT00305188 Evaluation of the Efficacy of Xaliproden (SR57746A) in Preventing the Neurotoxicity of Oxaliplatin / 5FU/LV Chemotherapy. Status COMPLETED Phase PHASE3